Platelet secretion and hemostasis require syntaxin-binding protein STXBP5

Journal of Clinical Investigation

Volumn 124, Issue 10, 2014, Pages 4517-4528

  Ye, Shaojing ^a   Huang, Yunjie ^a   Joshi, Smita ^a   Zhang, Jinchao ^a   Yang, Fanmuyi ^a   Zhang, Guoying ^a   Smyth, Susan S ^a   Li, Zhenyu ^a   Takai, Yoshimi ^b   Whiteheart, Sidney W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; HETERODIMER; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PADGEM PROTEIN; SECRETORY COMPONENT; SYNAPTOSOMAL ASSOCIATED PROTEIN 23; SYNTAXIN; SYNTAXIN 11; SYNTAXIN BINDING PROTEIN 5; UNCLASSIFIED DRUG; NERVE PROTEIN; SNARE PROTEIN; STXBP5 PROTEIN, HUMAN; SYNAPTOBREVIN; TOMOSYN PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELL COUNT; CELL ISOLATION; CELL STIMULATION; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; FLUORESCENCE ACTIVATED CELL SORTING; HEMOSTASIS; MASS SPECTROMETRY; MORPHOLOGY; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE RELEASE REACTION; ANIMAL; CELL FRACTIONATION; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; HUMAN; KNOCKOUT MOUSE; METABOLISM; PROTEIN MULTIMERIZATION; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CELL SEPARATION; FLOW CYTOMETRY; HEMOSTASIS; HUMANS; MASS SPECTROMETRY; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; P-SELECTIN; PROTEIN MULTIMERIZATION; R-SNARE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; SNARE PROTEINS; SUBCELLULAR FRACTIONS;

EID: 84907486928     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI75572     Document Type: Article

References (58)

1. Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov. 2010;9(2):154-169.
2. Lopes RD. Antiplatelet agents in cardiovascular disease. J Thromb Thrombolysis. 2011;31(3):306-309.
3. Michelson AD. Platelets. San Diego, California, USA: Elservier Science; 2002.
4. Graham GJ, Ren Q, Dilks JR, Blair P, Whiteheart SW, Flaumenhaft R. Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo. Blood. 2009;114(5):1083-1090.
5. Weber T, et al. SNAREpins: minimal machinery for membrane fusion. Cell. 1998;92(6):759-772.
6. Chen D, Bernstein AM, Lemons PP, Whiteheart SW. Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 in dense core granule release. Blood. 2000;95(3):921-929.
7. Chen D, Lemons PP, Schraw T, Whiteheart SW. Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 and 4 in lysosome release. Blood. 2000;96(5):1782-1788.
8. Bryceson YT, et al. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood. 2007;110(6):1906-1915.
9. Ye S, Karim ZA, Al Hawas R, Pessin JE, Filipovich AH, Whiteheart SW. Syntaxin-11, but not syntaxin-2 or syntaxin-4, is required for platelet secretion. Blood. 2012;120(12):2484-2492.
10. Sudhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM proteins. Science. 2009;323(5913):474-477.
11. Paumet F, Rahimian V, Rothman JE. The specificity of SNARE-dependent fusion is encoded in the SNARE motif. Proc Natl Acad Sci U S A. 2004;101(10):3376-3380.
12. Tolmachova T, Abrink M, Futter CE, Authi KS, Seabra MC. Rab27b regulates number and secretion of platelet dense granules. Proc Natl Acad Sci U S A. 2007;104(14):5872-5877.
13. Al Hawas R, Ren Q, Ye S, Karim ZA, Filipovich AH, Whiteheart SW. Munc18b/STXBP2 is required for platelet secretion. Blood. 2012;120(12):2493-2500.
14. Antoni G, et al. Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels. BMC Med Genet. 2011;12:102.
15. Campos M, et al. Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort. Blood. 2011;117(19):5224-5230.
16. Smith NL, et al. Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. Blood. 2011;117(22):6007-6011.
17. Smith NL, et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation. 2010;121(12):1382-1392.
18. Van Loon JE, Sanders YV, De Wee EM, Kruip MJ, De Maat MP, Leebeek FW. Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients. PLoS One. 2012;7(7):e40624.
19. Van Loon JE, et al. Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von Willebrand factor concentration and cardiovascular risk. Circ Cardiovasc Genet. 2010;3(6):507-512.
20. Huang J, et al. Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arterioscler Thromb Vasc Biol. 2014;34(5):1093-1101.
21. Fujita Y, et al. Tomosyn: a syntaxin-1-binding protein that forms a novel complex in the neurotransmitter release process. Neuron. 1998;20(5):905-915.
22. Widberg CH, Bryant NJ, Girotti M, Rea S, James DE. Tomosyn interacts with the t-SNAREs syntaxin4 and SNAP23 and plays a role in insulinstimulated GLUT4 translocation. J Biol Chem. 2003;278(37):35093-35101.
23. Scales SJ, Hesser BA, Masuda ES, Scheller RH. Amisyn, a novel syntaxin-binding protein that may regulate SNARE complex assembly. J Biol Chem. 2002;277(31):28271-28279.
24. Ashery U, Bielopolski N, Barak B, Yizhar O. Friends and foes in synaptic transmission: the role of tomosyn in vesicle priming. Trends Neurosci. 2009;32(5):275-282.
25. Lehman K, Rossi G, Adamo JE, Brennwald P. Yeast homologues of tomosyn and lethal giant larvae function in exocytosis and are associated with the plasma membrane SNARE, Sec9. J Cell Biol. 1999;146(1):125-140.
26. Gracheva EO, Burdina AO, Touroutine D, Berthelot-Grosjean M, Parekh H, Richmond JE. Tomosyn negatively regulates both synaptic transmitter and neuropeptide release at the C. elegans neuromuscular junction. J Physiol. 2007;585(pt 3):705-709.
27. Strand D, et al. The Drosophila lethal (2) giant larvae tumor suppressor protein forms homo-oligomers and is associated with nonmuscle myosin II heavy chain. J Cell Biol. 1994;127(5):1361-1373.
28. Pruyne DW, Schott DH, Bretscher A. Tropomyosin-containing actin cables direct the Myo2p-dependent polarized delivery of secretory vesicles in budding yeast. J Cell Biol. 1998;143(7):1931-1945.
29. Yokoyama S, Shirataki H, Sakisaka T, Takai Y. Three splicing variants of tomosyn and identification of their syntaxin-binding region. Biochem Biophys Res Commun. 1999;256(1):218-222.
30. Groffen AJ, Jacobsen L, Schut D, Verhage M. Two distinct genes drive expression of seven tomosyn isoforms in the mammalian brain, sharing a conserved structure with a unique variable domain. J Neurochem. 2005;92(3):554-568.
31. Hatsuzawa K, Lang T, Fasshauer D, Bruns D, Jahn R. The R-SNARE motif of tomosyn forms SNARE core complexes with syntaxin 1 and SNAP-25 and down-regulates exocytosis. J Biol Chem. 2003;278(33):31159-31166.
32. Sakisaka T, et al. Dual inhibition of SNARE complex formation by tomosyn ensures controlled neurotransmitter release. J Cell Biol. 2008;183(2):323-337.
33. Yizhar O, et al. Multiple functional domains are involved in tomosyn regulation of exocytosis. J Neurochem. 2007;103(2):604-616.
34. 2+-dependent exocytosis of neurotransmitter. J Cell Biol. 2005;170(7):1113-1125.
35. Cheviet S, et al. Tomosyn-1 is involved in a postdocking event required for pancreatic beta-cell exocytosis. J Cell Sci. 2006;119(pt 14):2912-2920.
36. Davis LK, et al. Novel copy number variants in children with autism and additional developmental anomalies. J Neurodev Disord. 2009;1(4):292-301.
37. Sandrock K, Nakamura L, Vraetz T, Beutel K, Ehl S, Zieger B. Platelet secretion defect in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5). Blood. 2010;116(26):6148-6150.
38. Hampson A, O'Connor A, Smolenski A. Synaptotagmin-like protein 4 and Rab8 interact and increase dense granule release in platelets. J Thromb Haemost. 2013;11(1):161-168.
39. Yizhar O, et al. Tomosyn inhibits priming of large dense-core vesicles in a calciumdependent manner. Proc Natl Acad Sci U S A. 2004;101(8):2578-2583.
40. Zhang W, et al. Tomosyn is expressed in betacells and negatively regulates insulin exocytosis. Diabetes. 2006;55(3):574-581.
41. Burkhart JM, Schumbrutzki C, Wortelkamp S, Sickmann A, Zahedi RP. Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomics. J Proteomics. 2012;75(4):1454-1462.
42. Rowley JW, et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood. 2011;118(14):e101-e111.
43. Falet H, Hoffmeister KM, Neujahr R, Hartwig JH. Normal Arp2/3 complex activation in platelets lacking WASp. Blood. 2002;100(6):2113-2122.
44. Bergmeier W, Stefanini L. Novel molecules in calcium signaling in platelets. J Thromb Haemost. 2009;7(suppl 1):187-190.
45. Buensuceso CS, Arias-Salgado EG, Shattil SJ. Protein-protein interactions in platelet alphaI-Ibbeta3 signaling. Semin Thromb Hemost. 2004;30(4):427-439.
46. Peters CG, Michelson AD, Flaumenhaft R. Granule exocytosis is required for platelet spreading: differential sorting of α-granules expressing VAMP-7. Blood. 2012;120(1):199-206.
47. Zhu Q, et al. Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion. J Clin Invest. 2014;124(10):4503-4516.
48. Sudhof TC, Rizo J. Synaptic vesicle exocytosis. Cold Spring Harb Perspect Biol. 2011;3(12):a005637.
49. Chen K, Richlitzki A, Featherstone DE, Schwarzel M, Richmond JE. Tomosyn-dependent regulation of synaptic transmission is required for a late phase of associative odor memory. Proc Natl Acad Sci U S A. 2011;108(45):18482-18487.
50. Brass LF, Tomaiuolo M, Stalker TJ. Harnessing the platelet signaling network to produce an optimal hemostatic response. Hematol Oncol Clin North Am. 2013;27(3):381-409.
51. Pastural E, et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet. 1997;16(3):289-292.
52. Knipe L, et al. A revised model for the secretion of tPA and cytokines from cultured endothelial cells. Blood. 2010;116(12):2183-2191.
53. Schraw TD, Lemons PP, Dean WL, Whiteheart SW. A role for Sec1/Munc18 proteins in platelet exocytosis. Biochem J. 2003;374(pt 1):207-217.
54. Schraw TD, et al. Granule stores from cellubrevin/VAMP-3 null mouse platelets exhibit normal stimulus-induced release. Blood. 2003;102(5):1716-1722.
55. Choi W, Karim ZA, Whiteheart SW. Arf6 plays an early role in platelet activation by collagen and convulxin. Blood. 2006;107(8):3145-3152.
56. Broze GJ Jr, Yin ZF, Lasky N. A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost. 2001;85(4):747-748.
57. Zhang G, et al. Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation. Blood. 2011;118(13):3670-3679.
58. Chrzanowska-Wodnicka M, Smyth SS, Schoenwaelder SM, Fischer TH, White GC 2nd. Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest. 2005;115(3):680-687.